Natasha A Koloski (N A Koloski, N Koloski, Natasha Koloski)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Venues

Digestive diseases and sciences

Alimentary pharmacology & therapeutics

BMJ open

Gut

Princess Alexandra Hospital

University of Sydney (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Princess Alexandra Hospital

Australia

Research Fellow :: Gastroenterology & Hepatology

Education History

University of Sydney

Australia

PHD :: Psychological Medicine

Publications

Dmitrii Kulin, Ayesha Shah, Thomas Fairlie, Reuben Kong Min Wong, Xiu Cai Fang, Uday Chand Ghoshal, Purna C Kashyap, Agata Mulak, Yeong Yeh Lee, Nicholas J Talley, Natasha A Koloski, Michael P Jones, Gerald J Holtmann
The COVID-19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta-analysis. Neurogastroenterology and motility (2024)
Natasha A Koloski, Kerith Duncanson, Shanthi Ann Ramanathan, Melanie Rao, Gerald Holtmann, Nicholas J Talley
What impact has the Centre of Research Excellence in Digestive Health made in the field of gastrointestinal health in Australia and internationally? Study protocol for impact evaluation using the FAIT framework. BMJ open 14 (3) (2024)
Natasha A Koloski, Ayesha Shah, Iain Kaan, Ronen Ben Jacob, Nicholas J Talley, Michael P Jones, Gerald J Holtmann
Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease. Digestive diseases and sciences 69 (5) (2024)
Natasha A Koloski, Kerith Duncanson, Shanthi Ann Ramanathan, Melanie Rao, Gerald Holtmann, Nicholas J Talley
What impact has the Centre of Research Excellence in Digestive Health made in the field of gastrointestinal health in Australia and internationally? Study protocol for impact evaluation using the FAIT framework. BMJ open 14 (3) (2024)
Natasha A Koloski, Ayesha Shah, Iain Kaan, Ronen Ben Jacob, Nicholas J Talley, Michael P Jones, Gerald J Holtmann
Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease. Digestive diseases and sciences 69 (5) (2024)
Natasha A Koloski, Ayesha Shah, Iain Kaan, Ronen Ben Jacob, Nicholas J Talley, Michael P Jones, Gerald J Holtmann
Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease. Digestive diseases and sciences 69 (5) (2024)
Natasha A Koloski, Kerith Duncanson, Shanthi Ann Ramanathan, Melanie Rao, Gerald Holtmann, Nicholas J Talley
What impact has the Centre of Research Excellence in Digestive Health made in the field of gastrointestinal health in Australia and internationally? Study protocol for impact evaluation using the FAIT framework. BMJ open 14 (3) (2024)
Natasha A Koloski, Ayesha Shah, Iain Kaan, Ronen Ben Jacob, Nicholas J Talley, Michael P Jones, Gerald J Holtmann
Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease. Digestive diseases and sciences 69 (5) (2024)
Natasha A Koloski, Ayesha Shah, Iain Kaan, Ronen Ben Jacob, Nicholas J Talley, Michael P Jones, Gerald J Holtmann
Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease. Digestive diseases and sciences (2024)
Natasha A Koloski, Kerith Duncanson, Shanthi Ann Ramanathan, Melanie Rao, Gerald Holtmann, Nicholas J Talley
What impact has the Centre of Research Excellence in Digestive Health made in the field of gastrointestinal health in Australia and internationally? Study protocol for impact evaluation using the FAIT framework. BMJ open 14 (3) (2024)
Nicholas J Talley, Gerald J Holtmann, Bridget R Southwell, David Fisher, Natasha A Koloski, Michael P Jones
Letter: non-invasive transabdominal stimulation device for the treatment of chronic constipation-proof-of-principle study in adults. Alimentary pharmacology & therapeutics 55 (10) (2022)
Erin R Shanahan, Seungha Kang, Heidi M Staudacher, Ayesha Shah, Anh Do, Grace Burns, Veronique S Chachay, Natasha A Koloski, Simon Keely, Marjorie M Walker, Nicholas J Talley, Mark Morrision, Gerald J Holtmann
Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia. Gut (2022)
Ayesha Shah, Seungha Kang, Nicholas J Talley, Anh Do, Marjorie M Walker, Erin R Shanahan, Natasha A Koloski, Michael P Jones, Simon Keely, Mark Morrision, Gerald J Holtmann
The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivity. Gut microbes 14 (1) (2022)
Natasha A Koloski, Michael P Jones, Marjorie M Walker, Michael Horowitz, Gerald J Holtmann, Nicholas J Talley
Diabetes mellitus is an independent risk factor for a greater frequency of early satiation and diarrhea at one and three years: Two prospective longitudinal population-based studies. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2022)
Natasha A Koloski, Michael P Jones, Marjorie M Walker, Simon Keely, Gerald J Holtmann, Nicholas J Talley
Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 Australians. Alimentary pharmacology & therapeutics 54 (5) (2021)
Nicholas J Talley, Marjorie M Walker, Michael P Jones, Simon Keely, Natasha A Koloski, Raquel Cameron, T Fairlie, G Burns, A Shah, T Hansen, G Harris, Gerald J Holtmann
Letter: budesonide for functional dyspepsia with duodenal eosinophilia-randomised, double-blind, placebo-controlled parallel-group trial. Alimentary pharmacology & therapeutics 53 (12) (2021)
Ayesha Shah, Nicholas J Talley, Natasha A Koloski, Graeme A Macdonald, Bradley J Kendall, Erin R Shanahan, Marjorie M Walker, Simon Keely, Michael P Jones, Mark Morrision, Gerald J Holtmann
Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease. Alimentary pharmacology & therapeutics 52 (1) (2020)
Nicholas J Talley, Gerald J Holtmann, Michael Jones, Natasha A Koloski, Marjorie M Walker, Grace Burns, Michael D E Potter, Ayesha Shah, Simon Keely
Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity. Gut 69 (9) (2019)
Ayesha Shah, Mark Morrison, Daniel Burger, Neal Martin, Justin Rich, Mike Jones, Natasha A Koloski, Marjorie M Walker, Nicholas J Talley, Gerald J Holtmann
Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Alimentary pharmacology & therapeutics 49 (6) (2019)
Natasha A Koloski, Michael Jones, Marjorie M Walker, Martin Veysey, Alkesh Zala, Simon Keely, Gerald J Holtmann, Nicholas J Talley
Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Alimentary pharmacology & therapeutics 49 (5) (2019)
Natasha A Koloski, M Jones, J Hammer, M von Wulffen, A Shah, H Hoelz, M Kutyla, D Burger, N Martin, S R Gurusamy, N J Talley, G Holtmann
The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting. Digestive diseases and sciences 62 (8) (2017)

Natasha A Koloski.css-eqlu8i{font-size:small;padding-left:4px;} (N A Koloski, N Koloski, Natasha Koloski)

Publication Activity (10 Years)

Top Topics

Top Venues

Natasha A Koloski (N A Koloski, N Koloski, Natasha Koloski)